[1]
« Berotralstat: A data review of a novel oral medication for the treatment of hereditary angioedema », Can Allergy Immunol Today, vol. 4, nᵒ 01-2, p. 2–8, janv. 2024, doi: 10.58931/cait.2024.4s0161.